ClassID:

20203

A61K31/075 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients Ethers or acetals

Sub-classes:
Recent Application in this class:
#1
20250387346
2025-12-25

ANTICANCER DRUG AND ANTICANCER DRUG SCREENING METHOD

#2
20250236578
2025-07-24

NOVEL CANNABINOID DERIVATIVES

#3
20250205286
2025-06-26

COMPOSITIONS, REAGENTS, AND METHODS FOR TREATING PITT-HOPKINS SYNDROME

#4
20240295545
2024-09-05

GLIOMA THERAPY

#5
20240254066
2024-08-01

RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF

#6
20240252453
2024-08-01

USE OF COMPOSITION OF ALCOHOL AND COOLING AGENT IN REGULATING SEXUAL FUNCTIONS, PROTECTING CARDIOVASCULAR AND CEREBROVASCULAR SYSTEMS, PROMOTING REGENERATION OF LIVER CELLS, PREVENTING AND/OR TREATING TUMORS, AND IMPROVING IMMUNITY AND SLEEP QUALITY

#7
20240066086
2024-02-29

Topical Hyperpigmentation Compositions and Method of Use

#8
20230302030
2023-09-28

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase

#9
20230049050
2023-02-16

EMULSIONS OF BIOACTIVE LIPOPHILIC COMPOUNDS INCLUDING OILS

#10
20230047106
2023-02-16

TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING A LOW CONCENTRATION OF BENZOYL PEROXIDE IN SUSPENSION IN WATER AND A WATER-MISCIBLE ORGANIC SOLVENT

#11
20220347072
2022-11-03

Method for removing keratotic plugs

#12
20220304942
2022-09-29

TREATMENT OF OBESITY AND RELATED CONDITIONS

#13
20220249395
2022-08-11

PHARMACEUTICAL FORMULATIONS FOR A LIQUID DOSAGE FORM AND A CONTROLLED RELEASE DOSAGE FORM

#14
20220211653
2022-07-07

COMPOSITIONS AND METHODS FOR INHIBITING BLOOD CANCER CELL GROWTH

#15
20220193087
2022-06-23

COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS

#16
20220126077
2022-04-28

Treatment for dry eyes

#17
20210378936
2021-12-09

NOVEL FORMULATIONS AND METHODS FOR TREATING DERMATOLOGICAL DISORDERS OR DISEASES

#18
20210322301
2021-10-21

DOSING REGIMENS FOR TREATING METAL-MEDIATED CONDITIONS

#19
20210290557
2021-09-23

MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION, IMMEDIATE RELEASE PELLETS, SUSTAINED RELEASE PELLETS, ENTERIC RELEASE PELLETS AND USE THEREOF

#20
20210128498
2021-05-06

Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide

#21
20200276218
2020-09-03

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#22
20200246365
2020-08-06

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE

#23
20200078366
2020-03-12

Combination therapies for the treatment of alzheimer's disease and related disorders

#24
20200060991
2020-02-27

METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE

#25
20190290639
2019-09-26

COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS

#26
20190151326
2019-05-23

Cancer therapy

#27
20190125776
2019-05-02

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#28
20190083220
2019-03-21

Oral compositions and methods of use

#29
20190056414
2019-02-21

Methods and dose packs for monitoring medication adherence

#30
20190038610
2019-02-07

Cancer therapy

#31
20190000866
2019-01-03

FOOD BASED DELIVERY OF THERAPEUTIC AGENT FOR TREATMENT OF HEPATIC ENCEPHALOPATHY

#32
20190000776
2019-01-03

Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage form

#33
20180344755
2018-12-06

Composition for treating neuropathy, process and method of treatment thereof

#34
20180289663
2018-10-11

Pharmaceutical composition for preventing or treating autoimmune diseases comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof

#35
20180289634
2018-10-11

Cosmetic composition for preventing or ameliorating hypersensitive skin comprising cedrol or derivatives thereof, or pharmaceutically acceptable salts thereof

#36
20180256513
2018-09-13

Method for the treatment or prevention of lower urinary tract symptoms

#37
20180256477
2018-09-13

Formulations and methods for treating dermatological disorders and diseases

#38
20180177791
2018-06-28

Combination therapies for the treatment of Alzheimer's disease and related disorders

#39
20180177790
2018-06-28

Combination therapies for the treatment of Alzheimer's disease and related disorders

#40
20180177789
2018-06-28

Combination therapies for the treatment of Alzheimer'S disease and related disorders

#41
20180164408
2018-06-14

LIDAR based 3-D imaging with far-field illumination overlap

#42
20180117033
2018-05-03

Composition and method for treating skin conditions

#43
20180110952
2018-04-26

METHODS AND APPARATUS FOR REDUCING ANXIETY IN A PATIENT

#44
20180104195
2018-04-19

ENHANCED DELIVERY EPINEPHRINE COMPOSITIONS

#45
20180036228
2018-02-08

DOSING REGIMENS FOR TREATING METAL-MEDIATED CONDITIONS

#46
20170340625
2017-11-30

Composition and method for treating skin conditions

#47
20170322231
2017-11-09

Methods and dose packs for monitoring medication adherence

#48
20170311687
2017-11-02

Aerosol composition for the prevention of symptoms of metal induced allergy and a method of synthesizing the same

#49
20170296489
2017-10-19

Cooling adjunct for medications to treat disorders in the nasal cavity

#50
20170216336
2017-08-03

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#51
20170209392
2017-07-27

Honey bee mite disruptive compounds and methods of application

#52
20170165220
2017-06-15

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#53
20170102398
2017-04-13

PREDICTING AND REDUCING COGNITIVE DECLINE BASED ON GSK-3 LEVELS

#54
20170071875
2017-03-16

Methods for treating occular irritation involving tearing by administering modulators of TRPM8

#55
20170065537
2017-03-09

Method for producing a flurane complex

#56
20170049728
2017-02-23

Method for treating vaginal dryness by administering transient receptor potential cation channel subfamily M member 8 (TRPM8) receptor agonists

#57
20160317470
2016-11-03

Agent for inhibiting odor of pyrazine derivatives

#58
20160310528
2016-10-27

Castration-resistant prostate cancer

#59
20160263124
2016-09-15

Compounds for the treatment of diabetes and disease complications arising from same

#60
20160220528
2016-08-04

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#61
20160168239
2016-06-16

Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders

#62
20160166588
2016-06-16

Use of edelfosine and other synthetic ether alkyl-lysophospholipids (APLs) for seizures and related diseases

#63
20160158192
2016-06-09

Combination therapies for the treatment of Alzheimer's disease and related disorders

#64
20160158191
2016-06-09

Combination therapies for the treatment of alzheimer's disease and related disorders

#65
20160101065
2016-04-14

Method for enhancing the bioavailability of ospemifene

#66
20160082027
2016-03-24

Composition for treating neuropathy, a process and a method of treatment thereof

#67
20160067192
2016-03-10

Anxiolytic effect of pterostilbene

#68
20160038478
2016-02-11

Composition and methods for treating skin conditions

#69
20150368187
2015-12-24

Inhibitors of the tumor necrosis factor receptor complex

#70
20150352059
2015-12-10

Method for the treatment or prevention of lower urinary tract symptoms

#71
20150313854
2015-11-05

Use of TRMP8 for treating opthalmic diseases or conditions involving tearing

#72
20150283113
2015-10-08

Combination therapies for the treatment of Alzheimer's disease and related disorders

#73
20150258079
2015-09-17

Cosmetic or dermatological preparation for prophylaxis and/or treatment of atopic dermatitis

#74
20150150828
2015-06-04

Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system

#75
20150141522
2015-05-21

Active substance combination of licochalcone A and phenoxyethanol

#76
20150126613
2015-05-07

Method for the treatment or prevention of lower urinary tract symptoms

#77
20150110901
2015-04-23

Sesquiterpenoid-based compounds, extracts of comprising the same, and use thereof

#78
20150056148
2015-02-26

Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay

#79
20150050368
2015-02-19

METHOD FOR PRODUCING A PLANT EXTRACT FROM DESMODIUM AND ITS EXTRACT THEREOF

#80
20140357729
2014-12-04

TOPICAL COMPOSITION CONTAINING SILICONE BASE

#81
20140315864
2014-10-23

Miliacin and sphingolipids and/or phospholipids composition for hair and scalp care

#82
20140303259
2014-10-09

Method for enhancing the bioavailability of ospemifene

#83
20140199373
2014-07-17

Formulations and methods for treating dermatological disorders or diseases

#84
20140193371
2014-07-10

Method for the treatment of tuberculosis

#85
20140134252
2014-05-15

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#86
20140050792
2014-02-20

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#87
20140038916
2014-02-06

O-(substituted benzyl) phosphoramidate compounds and therapeutic use

#88
20140037555
2014-02-06

Process for oral care material taste and/or odor improvement

#89
20140018422
2014-01-16

Derivatives of tetracaine

#90
20130273141
2013-10-17

Volatile anesthetic compositions and methods of use

#91
20130267718
2013-10-10

Amide gellant compositions containing isosorbide

#92
20130245231
2013-09-19

Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia

#93
20130224280
2013-08-29

TRANSDERMAL COMPOSITIONS AND METHODS FOR TREATING STRETCH MARKS

#94
20130217782
2013-08-22

Orally bioavailable stilbenoids-compositions and therapeutic applications thereof

#95
20130210775
2013-08-15

AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES

#96
20130123370
2013-05-16

Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system

#97
20130084257
2013-04-04

TRANSDERMAL ABSORPTION PROMOTER, AND EXTERNAL SKIN FORMULATION THEREOF

#98
20130078190
2013-03-28

Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay

#99
20130053335
2013-02-28

Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine

#100
20130029996
2013-01-31

SPECIAL COMPOSITION FOR THE USE THEREOF AS A DRUG

#101
20130023553
2013-01-24

PEGYLATED OPIOIDS WITH LOW POTENTIAL FOR ABUSE AND SIDE EFFECTS

#102
20130012460
2013-01-10

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#103
20130005824
2013-01-03

TREATMENT OF ISCHEMIC TISSUE

#104
20120329757
2012-12-27

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#105
20120283266
2012-11-08

Lysine Specific Demethylase-1 inhibitors and their use

#106
20120270952
2012-10-25

Method for enhancing the bioavailability of ospemifene

#107
20120269901
2012-10-25

Methods and Compounds Useful to Induce Apoptosis in Cancer Cells

#108
20120264804
2012-10-18

T TYPE CALCIUM CHANNEL BLOCKERS AND THE TREATMENT OF DISEASES

#109
20120244227
2012-09-27

BIOLOGICALLY ACTIVE FOOD ADDITIVE FOR THE PROPHYLAXIS OF OSTEOPOROSIS DISEASE

#110
20120115821
2012-05-10

COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS

#111
20120115812
2012-05-10

SURFACE COATINGS FOR SKIN

#112
20120114745
2012-05-10

METHOD FOR TREATING OR AMELIORATING MUCOCUTANEOUS OR OCULAR TOXICITIES

#113
20120100105
2012-04-26

AGENT AND METHOD FOR TREATING REFRACTORY CHRONIC HEPATITIS C

#114
20120010125
2012-01-12

Methods compounds and pharmaceutical compositions for treating anxiety and mood disorders

#115
20110312904
2011-12-22

Compounds, compositions and methods for reducing toxicity and treating or preventing diseases

#116
20110306671
2011-12-15

AMIDE DERIVATIVES OF ETHACRYNIC ACID

#117
20110294901
2011-12-01

FINELY PULVERIZED PHARMACEUTICAL COMPOSITION

#118
20110281945
2011-11-17

GASTRIC ACID SECRETION INHIBITOR, AND POTASSIUM CHANNEL INHIBITOR

#119
20110245285
2011-10-06

PROCESS FOR PREPARATION OF ROSUVASTATIN ACETONIDE CALCIUM

#120
20110224307
2011-09-15

Antimicrobial compositions comprising trimethylene glycol oligomer and methods of using the compositions

#121
20110207787
2011-08-25

Antimicrobial compositions

#122
20110189212
2011-08-04

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#123
20110166228
2011-07-07

COMPOSITION

#124
20110159078
2011-06-30

Volatile Anesthetic Compositions and Methods of Use

#125
20110137285
2011-06-09

KIT OF TAMPONING LIQUIDS AND A METHOD FOR THE TREATMENT OF TEARS AND/OR DETACHMENTS OF THE RETINA USING SUCH LIQUIDS

#126
20110135580
2011-06-09

Novel Medicament Combinations for the Treatment of Respiratory Diseases

#127
20110111057
2011-05-12

Methods and compounds useful to induce apoptosis in cancer cells

#128
20110097350
2011-04-28

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#129
20110033402
2011-02-10

Solubilized benzoyl small molecule

#130
20110009955
2011-01-13

Compounds and method for coating surfaces in a hemocompatible manner

#131
20100305158
2010-12-02

METHOD FOR THE TREATMENT OR PREVENTION OF LOWER URINARY TRACT SYMPTOMS

#132
20100280131
2010-11-04

Method for the alleviation of dyspareunia in women

#133
20100261729
2010-10-14

METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE

#134
20100240616
2010-09-23

NOVEL LIPID COMPOUNDS

#135
20100222406
2010-09-02

T Type Calcium Channel Blockers and the Treatment of Diseases

#136
20100216876
2010-08-26

ANTIDIARRHETIC COMPOSITION, PRODUCT CONTAINING THE SAME AND METHOD OF PREVENTING DIAHHREA

#137
20100216875
2010-08-26

METHODS OF TREATING ALZHEIMER'S DISEASE

#138
20100210733
2010-08-19

Composition for prevention or treatment of bone metabolism disorder comprising D-pinitol as an active ingredient

#139
20100204339
2010-08-12

Orally bioavailable stilbenoids—compositions and therapeutic applications thereof

#140
20100196507
2010-08-05

Treatment of Wounds and Compositions Employed

#141
20100152303
2010-06-17

AGENTS AND METHOD FOR INCREASING BRAIN CHAPERONIN LEVELS

#142
20100119499
2010-05-13

STILBENE-BASED COMPOSITIONS AND METHODS OF USE THEREFOR

#143
20100105631
2010-04-29

Inositol Compounds and Uses of Same in the Treatment of Diseases Characterized by Abnormal Protein Folding or Aggregation or Amyloid Formation, Desposition, Accumulation or Persistence

#144
20100093853
2010-04-15

Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes

#145
20100069486
2010-03-18

ANTI-TUMOR COMPOSITION

#146
20100048515
2010-02-25

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#147
20100047327
2010-02-25

Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same

#148
20100047187
2010-02-25

Methods of treating parkinson's disease using halogenated volatile compounds

#149
20100041759
2010-02-18

MULTI-PHASE RELEASE POTASSIUM GUAIACOLSULFONATE COMPOSITIONS

#150
20090324541
2009-12-31

Prophylactic or therapeutic agent for viral disease

#151
20090306172
2009-12-10

Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent

#152
20090209775
2009-08-20

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#153
20090202633
2009-08-13

Extended release formulations of guaifenesin

#154
20090170957
2009-07-02

SCYLLO-INOSITOL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DEPOSITION, ACCUMULATION OR PERSISTENCE

#155
20090093540
2009-04-09

Anti-tumor composition

#156
20090062402
2009-03-05

ACTIVE SUBSTANCE COMBINATION OF LICOCHALCONE A AND PHENOXYETHANOL

#157
20090041820
2009-02-12

Functional polymer compositions

#158
20090022831
2009-01-22

Use of and extracts thereof in preventing and decreasing toxic and side effects of antineoplastic drugs

#159
20090005339
2009-01-01

Methods of treating ear infections

#160
20080312337
2008-12-18

Anticancer composition comprising obovatol or obovatal

#161
20080312239
2008-12-18

METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION USING FISPEMIFENE

#162
20080274064
2008-11-06

Utilization of rhinologically active substances

#163
20080261865
2008-10-23

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#164
20080220091
2008-09-11

REDUCTION OF REACTIVE OXYGEN SPECIES IN CHRONIC WOUND MANAGEMENT

#165
20080206365
2008-08-28

Diterpene compounds having an atisane framework, compositions thereof, and methods of production

#166
20080119434
2008-05-22

Sir2a-based therapeutic and prophylactic methods

#167
20080085892
2008-04-10

Liquid dosage form of acetaminophen

#168
20080085312
2008-04-10

Multi-Phase Release Potassium Guaiacolsulfonate Compositions

#169
20080075793
2008-03-27

ANTIVIRAL COMPOSITIONS AND METHODS OF USE

#170
20080014261
2008-01-17

Non-narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction

#171
20080014252
2008-01-17

TOPICAL COMPOSITIONS WITH LONG LASTING EFFECT

#172
20080009498
2008-01-10

Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use

#173
20080008772
2008-01-10

Narcotic biphasic release compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction

#174
20070298121
2007-12-27

Treatment of Wounds and Compositions Employed

#175
20070270490
2007-11-22

USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA

#176
20070237807
2007-10-11

Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay

#177
20070232703
2007-10-04

Composition for preventing and/or treating bone disease, physiologically functional or health food containing thereof, and pharmaceutical containing thereof as active ingredients

#178
20070225330
2007-09-27

USE OF CERTAIN PHENYL-NAPHTHYL COMPOUNDS THAT DO NOT HAVE SIGNIFICANT AFFINITY TO ER ALPHA OR ER BETA FOR PROTECTION OF NEURONS AND OLIGODENDROCYTES IN THE TREATMENT OF MULTIPLE SCLEROSIS

#179
20070219162
2007-09-20

Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye

#180
20070190178
2007-08-16

Composition and method for the therapeutic modulation of matrix metalloproteinase

#181
20070185215
2007-08-09

Pharmaceutical composition containing obovatol as an active ingredient for the prevention and treatment of neurodegenerative diseases

#182
20070184040
2007-08-09

Compositions for delivery of coenzyme Q10

#183
20070167529
2007-07-19

Antimicrobial compositions for treating fabrics and surfaces

#184
20070148099
2007-06-28

Use of aroma compounds as defoaming agents for ophthalmic solutions with high concentrations of surfactants

#185
20070142539
2007-06-21

Octahydronaphthalene derivative and medicine

#186
20070128296
2007-06-07

Reduction of reactive oxygen species in chronic wound management

#187
20070122400
2007-05-31

Composition having liver function protecting effect

#188
20070111970
2007-05-17

Inositol compounds and uses of same in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, desposition, accumulation or persistence

#189
20070105931
2007-05-10

Methods and compositions for inhibiting the proliferation of prostate cancer cells

#190
20070104743
2007-05-10

Formulations of fispemifene

#191
20070104742
2007-05-10

Oral formulations of ospemifene

#192
20070099868
2007-05-03

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#193
20070098826
2007-05-03

Use of pinitol or chiroinositol for protecting the liver

#194
20070054967
2007-03-08

Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives)

#195
20070037889
2007-02-15

Anticancer composition comprising obovatol or obovatal

#196
20070015840
2007-01-18

Use of an alkyl ether of hydroxystilbene for the treatment of dry skin

#197
20070009611
2007-01-11

Treatment of wounds and compositions employed

#198
20060292253
2006-12-28

Active substance combination of licochalcone A and phenoxyethanol

#199
20060263302
2006-11-23

Systemic oxygenation via gastric perfusion with perfluorocarbon (PFC)

#200
20060258755
2006-11-16

Preparation of sevoflurane with negligible water content

#201
20060257501
2006-11-16

Composition and method for the therapeutic modulation of matrix metalloproteinase

#202
20060229364
2006-10-12

Antiviral compositions and methods of use

#203
20060228383
2006-10-12

Stable pharmaceutical composition of fluoroether compound for anesthetic use method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound

#204
20060142253
2006-06-29

Methods for treating neoplastic, angiogenic, vascular, fibroblastic, and/or immunosuppressive irregularities of the eye and/or joint via administration of combretastatin based medicaments, and iontophoretic devices for delivering combretastatin based medicaments

#205
20060142252
2006-06-29

Tubulin binding agents and corresponding prodrug constructs

#206
20060135625
2006-06-22

Method of administering split doses of a vascular targeting agent

#207
20060111450
2006-05-25

Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system

#208
20060052452
2006-03-09

Phenolic antiseptic compositions and methods of use

#209
20060029682
2006-02-09

Treatment of wounds and compositions employed

#210
20050281892
2005-12-22

Anti-tumor composition

#211
20050272825
2005-12-08

Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women

#212
20050272813
2005-12-08

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#213
20050272644
2005-12-08

Method for reducing radiation-induced normal tissue damage

#214
20050239903
2005-10-27

Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same

#215
20050228038
2005-10-13

11-Beta hydroxysteroid dehydrogenase type 1 inhibitors as anti-obesity/anti-diabetes compounds and 17-beta hydrosteroid dehydrogenase type I inhibitors as useful agents for the treatment of cancers, especially breast cancer

#216
20050228032
2005-10-13

Antimicrobial compositions

#217
20050220859
2005-10-06

Methods for treating illnesses of the tracheo-bronchial tract, especially chronic obstructive pulmonary disease (COPD)

#218
20050214379
2005-09-29

Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers

#219
20050208102
2005-09-22

Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases

#220
20050192353
2005-09-01

Treating or preventing restless legs syndrome using prodrugs of GABA analogs

#221
20050187302
2005-08-25

Method for treatment or prevention of osteoporosis in individuals with high bone turnover

#222
20050187301
2005-08-25

Solid formulations of ospemifene

#223
20050182143
2005-08-18

Method for enhancing the bioavailablity of ospemifene

#224
20050176678
2005-08-11

Compounds and method for coating surfaces in a haemocompatibe manner

#225
20050154066
2005-07-14

Antiaging composition

#226
20050148570
2005-07-07

Novel substituted alkane compounds and uses thereof

#227
20050148569
2005-07-07

Targeted oxidative therapeutic formulation

#228
20050148568
2005-07-07

Targeted oxidative therapeutic formulation

#229
20050136139
2005-06-23

Active substance combination of licochalcone a and phenoxyethanol

#230
20050124963
2005-06-09

Method for treating aspects of alcoholism, addiction and psychosis

#231
20050101678
2005-05-12

Antibacterial composition

#232
20050095288
2005-05-05

Decongestant and expectorant tablets

#233
20050075396
2005-04-07

Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia

#234
20050074497
2005-04-07

Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases

#235
20050042213
2005-02-24

Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof

#236
20050038125
2005-02-17

Method for the treatment of arthritis and pain

#237
20050027017
2005-02-03

Utilization of rhinologically active substances

#238
20050027000
2005-02-03

Methods and compounds useful to induce apoptosis in cancer cells

#239
15895312
2018-05-15

Combination therapies for the treatment of Alzheimer's disease and related disorders

#240
12732585
2018-10-23

Method of treatment for periodontal pockets